Interpace Diagnostics’ CEO Interviewed on The RedChip Money Report
PARSIPPANY, N.J., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG), a fully integrated commercial company that provides clinically useful molecular diagnostic tests and pathology services for improved patient diagnosis and …